Synthetic Biology Market

Synthetic Biology Market by Tools (Oligonucleotides, Enzymes, Synthetic Cells), Technology (Genome Engineering, Bioinformatics), Applications (Tissue Regeneration, Biofuel, Food, Agriculture, Consumer Care, Environmental)- Global Forecast to 2027

Report Code: BT 2910 Feb, 2023, by marketsandmarkets.com

The global synthetic biology market in terms of revenue was estimated to be worth $11.4 billion in 2022 and is poised to reach $35.7 billion by 2027, growing at a CAGR of 25.6% from 2022 to 2027. Various elements such as decreasing cost of DNA sequencing and synthesizing, increased government funding for synthetic biology research are boosting the growth of this market. However, biosafety, biosecurity, and ethical concerns related to synthetic biology are likely to hinder the growth of this market.

Synthetic Biology Market

To know about the assumptions considered for the study, Request for Free Sample Report

Synthetic Biology Market Dynamics

Driver: Increased Funding is likely to upsurge the market growth

Synthetic biomedicine research has gained momentum, owing to the depleting antibiotic pipeline, rising incidence of chronic and debilitating disorders such as cancer and HIV; and growing need to develop effective and promising cures for several diseases that adversely affect the quality of life across the globe. The continuous rise in the funding for synthetic biology by government agencies is further supporting the growth of this market. For instance, in July 2022, SynbiCITE, UK’s National Centre for the Industrial Translation of Synthetic Biology received USD 5.7 million (£5.5m) funding commitment from SynBioVen. Founded 2022, SynBioVen is a venture capital investment firm based in United Kingdom. The firm focuses to invest across the healthcare and biotechnology sectors. The funding will enable the Imperial-hosted centre to continue to support synthetic biology startups and SMEs, strengthen the emerging UK bioeconomy and help unlock the societal benefits of synthetic biology.

Restraint: Biosafety, biosecurity, and ethical concerns

One important biosafety concern in synthetic biology is the intentional or unintentional release of synthetic organisms into the environment during research and other applications. Synthetic microbes, when released into the environment, can mutate or interact with other organisms, resulting in crossbreeding with natural organisms and creating bio errors. This can threaten the ecosystem of natural organisms. The formation of antibiotic-resistant superbugs is another major biosafety concern. In recent years, the European Union (EU) has funded several research efforts on the environmental impact of deliberately released genetically engineered microbes for plant growth or bioremediation.

Opportunity: Use of Machine Learning in research and development

In recent years, artificial intelligence (AI)/machine learning has emerged as a plausible alternative to systems biology for the elucidation of biological phenomena and in attaining specified design objective in synthetic biology. The current development of artificial intelligence (AI) and machine learning (ML) techniques and tools in the biological and biotechnological domains can be viewed similarly for bringing about smarter and more automated analysis and decision-making to these fields. AI/ML remains an alternative for investigating system behaviors and improving the output of interest in synthetic biology applications. Currently various market players shifted the focus on machine learning use in synthetic biology. Additionally, immensive government support This is likely to create lucrative growth opportunities in coming years. For instance, as of November 2022, BigHat Biosciences, Inc., a biotechnology company with a machine learning-guided antibody discovery and development platform entered in collaboration with Merck to develop AI-enabled platform to expedite protein engineering to design and develop novel therapeutic candidates. Under the collaboration, BigHat and Merck will collaborate to optimize up to three proteins by leveraging BigHat’s platform to synthesize, express, purify, and characterize molecules.

The oligonucleotides & synthetic DNA segment dominated the synthetic biology market in 2021.

Based on tool, the synthetic biology market is broadly segmented into oligonucleotides & synthetic DNA, enzymes, cloning technology kits, synthetic cells, chassis organisms, and xeno-nucleic acids. In 2021, oligonucleotides & synthetic DNA accounted for the dominant share in synthetic biology market. This segment's large share can be attributed to factors such as rising demand for synthetic DNA and oligonucleotides. Furthermore, key market players focusing on launching of new products in the market is likely to upsurge the growth of the segment.

The medical applications segment is expected to grow at the highest CAGR during the forecast period.

Based on application, the synthetic biology market is segmented into medical applications, industrial applications, food & agriculture, and environmental applications. The medical applications segment is expected to register the highest CAGR during the forecast period. Increased investment in development of novel therapeutics through synthetic biology is one the factor driving the market growth. Need of fuel alternative is increasing adoption of synthetic biology hence propelling market growth.

Synthetic Biology Market by Region

North America dominated synthetic biology market in 2021.

Geographically, the synthetic biology market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. In 2021, North America accounted for the largest share in synthetic biology market, followed by Europe and the Asia Pacific. The large share of the North American market is owing to various factors such as increased use synthetic biology techniques across various industries such as medical, agriculture and others. Increased research funding for synthetic biology is furthermore driving the market growth in North America.

Key players in the synthetic biology market are Thermo Fisher Scientific, Inc. (US), Merck KGaA (Germany), Agilent Technologies (US), Novozymes (Denmark), Ginkgo Bioworks (US), Amyris (US), Precigen, Inc. (US), GenScript (China), Twist Bioscience (US), Synthetic Genomics (US), Codexis (US), Synthego (US), Creative Enzymes (US), and Eurofins Scientific (Luxembourg).

Synthetic Biology Market Report Scope

Report Metrics

Details

Market Revenue in 2022

$11.4 billion

Estimated Value by 2027

$35.7 billion

Growth Rate

Poised to grow at a CAGR of 25.6%

Market Dynamics

Drivers, Opportunities, Restraints & Challenges

Market Segmentation

Tools, Technology, Application, And Region

Geographies Covered

North America, Europe, Asia Pacific, Latin America, and Middle East & Africa

This report categorizes the synthetic biology market into the following segments and subsegments:

By Tool

  • Oligonucleotides and Synthetic DNA
  • Enzymes
  • Cloning Technologies Kits
  • Synthetic Cells
  • Chassis Organisms
  • Xeno-nucleic Acids

By Technology

  • Gene Synthesis
  • Genome Engineering
  • Sequencing
  • Bioinformatics
  • Site-directed Mutagenesis
  • Cloning
  • Measurement and Modelling
  • Microfluidics
  • Nanotechnology

By Application

  • Medical Application
    • Pharmaceuticals
    • Drug Discovery and Therapeutics
      • Cancer Detection & Diagnostics
      • Other Drug Discovery and Therapeutic Applications
  • Artificial Tissue and Tissue Regeneration
    • Bio-synthesis
    • Stem Cell Regulation
    • Other Tissue and Tissue Regeneration Applications
  • Industrial Applications
    • Biofuel and Renewable Energy
    • Biomaterials and Green Chemicals
    • Industrial Enzymes, by Application
      • Textile Industry
      • Paper Industry
      • Consumer Care Industry
        • Skin Care & Cosmetics
        • Other Consumer Care Products
      • Other Industries
  • Food & Agriculture
  • Environmental Applications

Recent Developments:

  • In January 2021, Novozymes launched Frontia GlutenEx. It would help wheat processors increase their gluten protein recovery and, at the same time, cut down on energy consumption.
  • In February 2021, Merck partnered with BioNTech (Germany) to supply lipids for the production of Pfizer-BioNTech COVID-19 Vaccine (BNT162b2).
  • In January 2021, Merck acquired AmpTec (Germany). With this acquisition, the company strengthened its product portfolio to develop and manufacture mRNA for utilizing vaccines, treatments, and diagnostics.

Frequently Asked Questions (FAQ):

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

TABLE OF CONTENTS
 
1 INTRODUCTION (Page No. - 56)
    1.1 STUDY OBJECTIVES 
    1.2 MARKET DEFINITION AND SCOPE 
           1.2.1 INCLUSIONS AND EXCLUSIONS
           1.2.2 MARKETS COVERED
           1.2.3 YEARS CONSIDERED
    1.3 CURRENCY 
    1.4 STAKEHOLDERS 
    1.5 LIMITATIONS 
    1.6 SUMMARY OF CHANGES 
    1.7 RECESSION IMPACT 
 
2 RESEARCH METHODOLOGY (Page No. - 61)
    2.1 RESEARCH APPROACH 
          FIGURE 1 RESEARCH DESIGN
           2.1.1 SECONDARY DATA
           2.1.2 PRIMARY RESEARCH
                    FIGURE 2 SYNTHETIC BIOLOGY MARKET: PRIMARY RESPONDENTS
    2.2 MARKET ESTIMATION METHODOLOGY 
           2.2.1 AVERAGE MARKET SIZE ESTIMATION (2021)
           2.2.2 REVENUE MAPPING-BASED MARKET ESTIMATION
                    FIGURE 3 MARKET SIZE ESTIMATION: REVENUE-BASED ESTIMATION METHODOLOGY
    2.3 DATA TRIANGULATION 
          FIGURE 4 DATA TRIANGULATION METHODOLOGY
    2.4 GROWTH RATE ASSUMPTIONS 
    2.5 GROWTH FORECAST 
          FIGURE 5 GROWTH RATE ANALYSIS FOR SYNTHETIC BIOLOGY MARKET
    2.6 RISK ASSESSMENT 
    2.7 INSIGHTS FROM PRIMARY EXPERTS 
    2.8 RECESSION IMPACT 
          TABLE 1 GLOBAL INFLATION RATE PROJECTIONS, 2021–2027
 
3 EXECUTIVE SUMMARY (Page No. - 71)
    FIGURE 6 SYNTHETIC BIOLOGY MARKET, BY TOOL, 2022 VS. 2027 (USD MILLION)
    FIGURE 7 SYNTHETIC BIOLOGY MARKET, BY TECHNOLOGY, 2022 VS. 2027 (USD MILLION)
    FIGURE 8 SYNTHETIC BIOLOGY MARKET, BY APPLICATION, 2022 VS. 2027 (USD MILLION)
    FIGURE 9 REGIONAL SNAPSHOT OF SYNTHETIC BIOLOGY MARKET
 
4 PREMIUM INSIGHTS (Page No. - 75)
    4.1 SYNTHETIC BIOLOGY MARKET OVERVIEW 
          FIGURE 10 DIVERSE APPLICATIONS OF SYNTHETIC BIOLOGY TO DRIVE MARKET
    4.2 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET, BY APPLICATION AND COUNTRY (2021) 
          FIGURE 11 US ACCOUNTED FOR LARGEST SHARE OF NORTH AMERICAN SYNTHETIC BIOLOGY MARKET IN 2021
    4.3 SYNTHETIC BIOLOGY MARKET SHARE, BY APPLICATION, 2021 
          FIGURE 12 MEDICAL APPLICATIONS SEGMENT ACCOUNTED FOR LARGEST MARKET SHARE IN 2021
    4.4 SYNTHETIC BIOLOGY MARKET: REGIONAL GROWTH OPPORTUNITIES 
          FIGURE 13 ASIA PACIFIC TO WITNESS HIGHEST GROWTH DURING FORECAST PERIOD
 
5 MARKET OVERVIEW (Page No. - 79)
    5.1 INTRODUCTION 
    5.2 MARKET DYNAMICS 
          FIGURE 14 SYNTHETIC BIOLOGY MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES,  AND CHALLENGES
          TABLE 2 SYNTHETIC BIOLOGY MARKET: IMPACT ANALYSIS
           5.2.1 DRIVERS
                    5.2.1.1 Diverse applications of synthetic biology
                    5.2.1.2 Increased funding for research in synthetic biology
                    5.2.1.3 Declining cost of DNA sequencing and synthesizing
                                FIGURE 15 REDUCTION IN COST PER RAW MEGABASE OF DNA SEQUENCING (USD),  2010–2020
                    5.2.1.4 Innovations in synthetic biology
           5.2.2 RESTRAINTS
                    5.2.2.1 Biosafety, biosecurity, and ethical concerns
           5.2.3 OPPORTUNITIES
                    5.2.3.1 Increasing demand for fuel alternatives
                    5.2.3.2 Growth in research on synthetic drugs and vaccines
                                TABLE 3 CLINICAL TRIALS UTILIZING ANTIGENS OR BIOLOGICAL MATERIALS IN VACCINES
                    5.2.3.3 Use of machine learning in research and development
           5.2.4 CHALLENGES
                    5.2.4.1 Standardization of biological parts
    5.3 TECHNOLOGY ANALYSIS 
          TABLE 4 COMPARISON OF MODERN GENE EDITING TOOLS
          TABLE 5 MACHINE LEARNING METHODS CURRENTLY APPLIED IN METABOLIC MODELS OF INDUSTRIAL MICROORGANISMS
    5.4 ECOSYSTEM ANALYSIS 
          FIGURE 16 ECOSYSTEM ANALYSIS: SYNTHETIC BIOLOGY MARKET
          TABLE 6 SYNTHETIC BIOLOGY MARKET: ROLE IN ECOSYSTEM
    5.5 PATENT ANALYSIS 
    5.6 PRICING ANALYSIS 
          TABLE 7 AVERAGE SELLING PRICE OF SYNTHETIC BIOLOGY PRODUCTS (2021)
          TABLE 8 SELLING PRICE OF VARIOUS PRODUCTS/SERVICES, BY KEY PLAYER
    5.7 PORTER’S FIVE FORCES ANALYSIS 
          TABLE 9 SYNTHETIC BIOLOGY MARKET: PORTER’S FIVE FORCES ANALYSIS
           5.7.1 THREAT OF NEW ENTRANTS
           5.7.2 THREAT OF SUBSTITUTES
           5.7.3 BARGAINING POWER OF SUPPLIERS
           5.7.4 BARGAINING POWER OF BUYERS
           5.7.5 INTENSITY OF COMPETITIVE RIVALRY
    5.8 VALUE CHAIN ANALYSIS 
          FIGURE 17 VALUE CHAIN ANALYSIS OF SYNTHETIC BIOLOGY MARKET: MANUFACTURING AND ASSEMBLY PHASES ADD MAXIMUM VALUE
    5.9 REGULATORY ANALYSIS 
           5.9.1 REGULATIONS FOR PRODUCTS DEVELOPED USING SYNTHETIC BIOLOGY TECHNIQUES
                    TABLE 10 REGULATIONS FOR PRODUCTS DEVELOPED USING SYNTHETIC BIOLOGY TECHNIQUES
           5.9.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
                    TABLE 11 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
                    TABLE 12 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
                    TABLE 13 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    5.10 KEY CONFERENCES AND EVENTS IN 2022–2023 
          TABLE 14 SYNTHETIC BIOLOGY MARKET: DETAILED LIST OF CONFERENCES AND EVENTS
    5.11 KEY STAKEHOLDERS AND BUYING CRITERIA 
           5.11.1 KEY STAKEHOLDERS IN BUYING PROCESS
                     FIGURE 18 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP THREE APPLICATIONS
                     TABLE 15 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP THREE APPLICATIONS
           5.11.2 BUYING CRITERIA
                     FIGURE 19 KEY BUYING CRITERIA FOR TOP THREE APPLICATIONS
    5.12 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS 
 
6 SYNTHETIC BIOLOGY MARKET, BY TOOL (Page No. - 103)
    6.1 INTRODUCTION 
          TABLE 16 SYNTHETIC BIOLOGY MARKET, BY TOOL, 2020–2027 (USD MILLION)
    6.2 OLIGONUCLEOTIDES AND SYNTHETIC DNA 
           6.2.1 INCREASING DEMAND FOR SYNTHETIC DNA TO SUPPORT MARKET GROWTH
                    TABLE 17 SYNTHETIC BIOLOGY MARKET FOR OLIGONUCLEOTIDES AND SYNTHETIC DNA, BY REGION, 2020–2027 (USD MILLION)
                    TABLE 18 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR OLIGONUCLEOTIDES AND SYNTHETIC DNA, BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 19 EUROPE: SYNTHETIC BIOLOGY MARKET FOR OLIGONUCLEOTIDES AND SYNTHETIC DNA, BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 20 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR OLIGONUCLEOTIDES AND SYNTHETIC DNA, BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 21 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR OLIGONUCLEOTIDES AND SYNTHETIC DNA, BY COUNTRY, 2020–2027 (USD MILLION)
    6.3 ENZYMES 
           6.3.1 LAUNCH OF NOVEL ENZYMES TO PROPEL MARKET
                    TABLE 22 SYNTHETIC BIOLOGY MARKET FOR ENZYMES, BY REGION, 2020–2027 (USD MILLION)
                    TABLE 23 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR ENZYMES, BY COUNTRY,  2020–2027 (USD MILLION)
                    TABLE 24 EUROPE: SYNTHETIC BIOLOGY MARKET FOR ENZYMES, BY COUNTRY,  2020–2027 (USD MILLION)
                    TABLE 25 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR ENZYMES, BY COUNTRY,  2020–2027 (USD MILLION)
                    TABLE 26 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR ENZYMES, BY COUNTRY,  2020–2027 (USD MILLION)
    6.4 CLONING TECHNOLOGY KITS 
           6.4.1 NEED FOR CREATION OF ARTIFICIAL DNA AND ASSEMBLY TO DRIVE MARKET
                    TABLE 27 SYNTHETIC BIOLOGY MARKET FOR CLONING TECHNOLOGY KITS, BY REGION,  2020–2027 (USD MILLION)
                    TABLE 28 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR CLONING TECHNOLOGY KITS,  BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 29 EUROPE: SYNTHETIC BIOLOGY MARKET FOR CLONING TECHNOLOGY KITS, BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 30 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR CLONING TECHNOLOGY KITS,  BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 31 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR CLONING TECHNOLOGY KITS,  BY COUNTRY, 2020–2027 (USD MILLION)
    6.5 SYNTHETIC CELLS 
           6.5.1 RISING DEMAND FOR SYNTHETIC CELLS TO SUPPORT MARKET GROWTH
                    TABLE 32 SYNTHETIC BIOLOGY MARKET FOR SYNTHETIC CELLS, BY REGION,  2020–2027 (USD MILLION)
                    TABLE 33 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR SYNTHETIC CELLS, BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 34 EUROPE: SYNTHETIC BIOLOGY MARKET FOR SYNTHETIC CELLS, BY COUNTRY,  2020–2027 (USD MILLION)
                    TABLE 35 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR SYNTHETIC CELLS, BY COUNTRY,  2020–2027 (USD MILLION)
                    TABLE 36 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR SYNTHETIC CELLS, BY COUNTRY, 2020–2027 (USD MILLION)
    6.6 CHASSIS ORGANISMS 
           6.6.1 INCREASING DEMAND FOR FOSSIL FUELS TO PROPEL MARKET
                    TABLE 37 SYNTHETIC BIOLOGY MARKET FOR CHASSIS ORGANISMS, BY REGION,  2020–2027 (USD MILLION)
                    TABLE 38 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR CHASSIS ORGANISMS, BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 39 EUROPE: SYNTHETIC BIOLOGY MARKET FOR CHASSIS ORGANISMS, BY COUNTRY,  2020–2027 (USD MILLION)
                    TABLE 40 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR CHASSIS ORGANISMS, BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 41 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR CHASSIS ORGANISMS, BY COUNTRY, 2020–2027 (USD MILLION)
    6.7 XENO NUCLEIC ACIDS 
           6.7.1 GROWING DEMAND FOR BREAKTHROUGH MEDICINES TO SUPPORT MARKET GROWTH
                    TABLE 42 SYNTHETIC BIOLOGY MARKET FOR XENO NUCLEIC ACIDS, BY REGION,  2020–2027 (USD MILLION)
                    TABLE 43 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR XENO NUCLEIC ACIDS, BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 44 EUROPE: SYNTHETIC BIOLOGY MARKET FOR XENO NUCLEIC ACIDS, BY COUNTRY,  2020–2027 (USD MILLION)
                    TABLE 45 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR XENO NUCLEIC ACIDS, BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 46 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR XENO NUCLEIC ACIDS, BY COUNTRY, 2020–2027 (USD MILLION)
 
7 SYNTHETIC BIOLOGY MARKET, BY TECHNOLOGY (Page No. - 123)
    7.1 INTRODUCTION 
          TABLE 47 SYNTHETIC BIOLOGY MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)
    7.2 GENE SYNTHESIS 
           7.2.1 GENE SYNTHESIS TO DOMINATE MARKET DURING  FORECAST PERIOD
                    TABLE 48 SYNTHETIC BIOLOGY MARKET FOR GENE SYNTHESIS, BY REGION,  2020–2027 (USD MILLION)
                    TABLE 49 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR GENE SYNTHESIS, BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 50 EUROPE: SYNTHETIC BIOLOGY MARKET FOR GENE SYNTHESIS, BY COUNTRY,  2020–2027 (USD MILLION)
                    TABLE 51 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR GENE SYNTHESIS, BY COUNTRY,  2020–2027 (USD MILLION)
                    TABLE 52 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR GENE SYNTHESIS, BY COUNTRY, 2020–2027 (USD MILLION)
    7.3 GENOME ENGINEERING 
           7.3.1 INCREASING DEMAND FOR SYNTHETIC DNA AND GENES TO DRIVE MARKET
                    TABLE 53 SYNTHETIC BIOLOGY MARKET FOR GENOME ENGINEERING, BY REGION,  2020–2027 (USD MILLION)
                    TABLE 54 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR GENOME ENGINEERING,  BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 55 EUROPE: SYNTHETIC BIOLOGY MARKET FOR GENOME ENGINEERING, BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 56 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR GENOME ENGINEERING, BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 57 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR GENOME ENGINEERING, BY COUNTRY, 2020–2027 (USD MILLION)
    7.4 SEQUENCING 
           7.4.1 NGS TECHNOLOGY REQUISITE FOR BIOLOGICAL RESEARCH
                    TABLE 58 SYNTHETIC BIOLOGY MARKET FOR SEQUENCING, BY REGION,  2020–2027 (USD MILLION)
                    TABLE 59 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR SEQUENCING, BY COUNTRY,  2020–2027 (USD MILLION)
                    TABLE 60 EUROPE: SYNTHETIC BIOLOGY MARKET FOR SEQUENCING, BY COUNTRY,  2020–2027 (USD MILLION)
                    TABLE 61 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR SEQUENCING, BY COUNTRY,  2020–2027 (USD MILLION)
                    TABLE 62 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR SEQUENCING, BY COUNTRY,  2020–2027 (USD MILLION)
    7.5 BIOINFORMATICS 
           7.5.1 RISING NEED FOR DATA MANAGEMENT AND CURATION TO DRIVE ADOPTION OF BIOINFORMATICS TECHNOLOGIES
                    TABLE 63 SYNTHETIC BIOLOGY MARKET FOR BIOINFORMATICS, BY REGION,  2020–2027 (USD MILLION)
                    TABLE 64 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR BIOINFORMATICS, BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 65 EUROPE: SYNTHETIC BIOLOGY MARKET FOR BIOINFORMATICS, BY COUNTRY,  2020–2027 (USD MILLION)
                    TABLE 66 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR BIOINFORMATICS, BY COUNTRY,  2020–2027 (USD MILLION)
                    TABLE 67 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR BIOINFORMATICS, BY COUNTRY, 2020–2027 (USD MILLION)
    7.6 CLONING 
           7.6.1 CLONING AIDS IN BUILDING NEW GENETIC MODULES/PATHWAYS, ENABLING RAPID ADVANCES IN RESEARCH ACROSS INDUSTRIES
                    TABLE 68 SYNTHETIC BIOLOGY MARKET FOR CLONING, BY REGION,  2020–2027 (USD MILLION)
                    TABLE 69 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR CLONING, BY COUNTRY,  2020–2027 (USD MILLION)
                    TABLE 70 EUROPE: SYNTHETIC BIOLOGY MARKET FOR CLONING, BY COUNTRY,  2020–2027 (USD MILLION)
                    TABLE 71 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR CLONING, BY COUNTRY,  2020–2027 (USD MILLION)
                    TABLE 72 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR CLONING, BY COUNTRY,  2020–2027 (USD MILLION)
    7.7 SITE-DIRECTED MUTAGENESIS 
           7.7.1 WIDE APPLICATIONS IN GENETIC ENGINEERING, DNA ASSEMBLY, AND CLONING TECHNOLOGIES TO DRIVE MARKET
                    TABLE 73 SYNTHETIC BIOLOGY MARKET FOR SITE-DIRECTED MUTAGENESIS, BY REGION,  2020–2027 (USD MILLION)
                    TABLE 74 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR SITE-DIRECTED MUTAGENESIS,  BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 75 EUROPE: SYNTHETIC BIOLOGY MARKET FOR SITE-DIRECTED MUTAGENESIS, BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 76 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR SITE-DIRECTED MUTAGENESIS,  BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 77 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR SITE-DIRECTED MUTAGENESIS,  BY COUNTRY, 2020–2027 (USD MILLION)
    7.8 MEASUREMENT AND MODELING 
           7.8.1 CELL-FREE SYNTHETIC BIOLOGY EMERGING AS POWERFUL TECHNOLOGY
                    TABLE 78 SYNTHETIC BIOLOGY MARKET FOR MEASUREMENT AND MODELING, BY REGION,  2020–2027 (USD MILLION)
                    TABLE 79 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR MEASUREMENT AND MODELING,  BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 80 EUROPE: SYNTHETIC BIOLOGY MARKET FOR MEASUREMENT AND MODELING,  BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 81 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR MEASUREMENT AND MODELING,  BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 82 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR MEASUREMENT AND MODELING,  BY COUNTRY, 2020–2027 (USD MILLION)
    7.9 MICROFLUIDICS 
           7.9.1 DROPLET MICROFLUIDICS GAINING WIDE RECOGNITION IN FIELD OF SYNTHETIC BIOLOGY
                    TABLE 83 SYNTHETIC BIOLOGY MARKET FOR MICROFLUIDICS, BY REGION,  2020–2027 (USD MILLION)
                    TABLE 84 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR MICROFLUIDICS, BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 85 EUROPE: SYNTHETIC BIOLOGY MARKET FOR MICROFLUIDICS, BY COUNTRY,  2020–2027 (USD MILLION)
                    TABLE 86 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR MICROFLUIDICS, BY COUNTRY,  2020–2027 (USD MILLION)
                    TABLE 87 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR MICROFLUIDICS, BY COUNTRY, 2020–2027 (USD MILLION)
    7.10 NANOTECHNOLOGY 
           7.10.1 CONVERGENCE BETWEEN SYNTHETIC BIOLOGY AND NANOTECHNOLOGY AIDS IN BUILDING COMPLEX BODIES
                     TABLE 88 SYNTHETIC BIOLOGY MARKET FOR NANOTECHNOLOGY, BY REGION,  2020–2027 (USD MILLION)
                     TABLE 89 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR NANOTECHNOLOGY, BY COUNTRY, 2020–2027 (USD MILLION)
                     TABLE 90 EUROPE: SYNTHETIC BIOLOGY MARKET FOR NANOTECHNOLOGY, BY COUNTRY,  2020–2027 (USD MILLION)
                     TABLE 91 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR NANOTECHNOLOGY, BY COUNTRY, 2020–2027 (USD MILLION)
                     TABLE 92 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR NANOTECHNOLOGY, BY COUNTRY, 2020–2027 (USD MILLION)
 
8 SYNTHETIC BIOLOGY MARKET, BY APPLICATION (Page No. - 153)
    8.1 INTRODUCTION 
          TABLE 93 SYNTHETIC BIOLOGY MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
    8.2 MEDICAL APPLICATIONS 
          TABLE 94 SYNTHETIC BIOLOGY MARKET FOR MEDICAL APPLICATIONS, BY TYPE,  2020–2027 (USD MILLION)
          TABLE 95 SYNTHETIC BIOLOGY MARKET FOR MEDICAL APPLICATIONS, BY REGION,  2020–2027 (USD MILLION)
          TABLE 96 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR MEDICAL APPLICATIONS,  BY COUNTRY, 2020–2027 (USD MILLION)
          TABLE 97 EUROPE: SYNTHETIC BIOLOGY MARKET FOR MEDICAL APPLICATIONS, BY COUNTRY, 2020–2027(USD MILLION)
          TABLE 98 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR MEDICAL APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION)
          TABLE 99 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR MEDICAL APPLICATIONS,  BY COUNTRY, 2020–2027 (USD MILLION)
           8.2.1 PHARMACEUTICALS
                    8.2.1.1 Largest synthetic biology market for medical applications
                                TABLE 100 SYNTHETIC BIOLOGY MARKET FOR PHARMACEUTICALS, BY REGION,  2020–2027 (USD MILLION)
                                TABLE 101 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR PHARMACEUTICALS, BY COUNTRY, 2020–2027 (USD MILLION)
                                TABLE 102 EUROPE: SYNTHETIC BIOLOGY MARKET FOR PHARMACEUTICALS, BY COUNTRY,  2020–2027 (USD MILLION)
                                TABLE 103 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR PHARMACEUTICALS, BY COUNTRY, 2020–2027 (USD MILLION)
                                TABLE 104 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR PHARMACEUTICALS, BY COUNTRY, 2020–2027 (USD MILLION)
           8.2.2 DRUG DISCOVERY AND THERAPEUTICS
                    TABLE 105 SYNTHETIC BIOLOGY MARKET FOR DRUG DISCOVERY AND THERAPEUTICS, BY TYPE, 2020–2027 (USD MILLION)
                    TABLE 106 SYNTHETIC BIOLOGY MARKET FOR DRUG DISCOVERY AND THERAPEUTICS, BY REGION,  2020–2027 (USD MILLION)
                    TABLE 107 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR DRUG DISCOVERY AND THERAPEUTICS, BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 108 EUROPE: SYNTHETIC BIOLOGY MARKET FOR DRUG DISCOVERY AND THERAPEUTICS,  BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 109 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR DRUG DISCOVERY AND THERAPEUTICS, BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 110 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR DRUG DISCOVERY AND THERAPEUTICS, BY COUNTRY, 2020–2027 (USD MILLION)
                    8.2.2.1 Cancer detection and diagnostics
                               8.2.2.1.1 Increasing investments in cancer research to support market
                                              TABLE 111 SYNTHETIC BIOLOGY MARKET FOR CANCER DETECTION AND DIAGNOSTICS, BY REGION,  2020–2027 (USD MILLION)
                                              TABLE 112 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR CANCER DETECTION AND DIAGNOSTICS, BY COUNTRY, 2020–2027 (USD MILLION)
                                              TABLE 113 EUROPE: SYNTHETIC BIOLOGY MARKET FOR CANCER DETECTION AND DIAGNOSTICS,  BY COUNTRY, 2020–2027 (USD MILLION)
                                              TABLE 114 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR CANCER DETECTION AND DIAGNOSTICS, BY COUNTRY, 2020–2027 (USD MILLION)
                                              TABLE 115 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR CANCER DETECTION AND DIAGNOSTICS, BY COUNTRY, 2020–2027 (USD MILLION)
                    8.2.2.2 Other drug discovery and therapeutic applications
                                TABLE 116 SYNTHETIC BIOLOGY MARKET FOR OTHER DRUG DISCOVERY AND THERAPEUTIC APPLICATIONS, BY REGION, 2020–2027 (USD MILLION)
                                TABLE 117 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR OTHER DRUG DISCOVERY AND THERAPEUTIC APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION)
                                TABLE 118 EUROPE: SYNTHETIC BIOLOGY MARKET FOR OTHER DRUG DISCOVERY AND THERAPEUTIC APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION)
                                TABLE 119 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR OTHER DRUG DISCOVERY AND THERAPEUTIC APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION)
                                TABLE 120 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR OTHER DRUG DISCOVERY AND THERAPEUTIC APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION)
           8.2.3 ARTIFICIAL TISSUE AND TISSUE REGENERATION
                    TABLE 121 SYNTHETIC BIOLOGY MARKET FOR ARTIFICIAL TISSUE AND TISSUE REGENERATION,  BY TYPE, 2020–2027 (USD MILLION)
                    TABLE 122 SYNTHETIC BIOLOGY MARKET FOR ARTIFICIAL TISSUE AND TISSUE REGENERATION,  BY REGION, 2020–2027 (USD MILLION)
                    TABLE 123 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR ARTIFICIAL TISSUE AND TISSUE REGENERATION, BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 124 EUROPE: SYNTHETIC BIOLOGY MARKET FOR ARTIFICIAL TISSUE AND TISSUE REGENERATION, BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 125 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR ARTIFICIAL TISSUE AND TISSUE REGENERATION, BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 126 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR ARTIFICIAL TISSUE AND TISSUE REGENERATION, BY COUNTRY, 2020–2027 (USD MILLION)
                    8.2.3.1 Biosynthesis
                               8.2.3.1.1 Largest market due to increasing need to create artificial genomes
                                              TABLE 127 SYNTHETIC BIOLOGY MARKET FOR BIOSYNTHESIS, BY REGION,  2020–2027 (USD MILLION)
                                              TABLE 128 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR BIOSYNTHESIS, BY COUNTRY,  2020–2027 (USD MILLION)
                                              TABLE 129 EUROPE: SYNTHETIC BIOLOGY MARKET FOR BIOSYNTHESIS, BY COUNTRY,  2020–2027 (USD MILLION)
                                              TABLE 130 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR BIOSYNTHESIS, BY COUNTRY,  2020–2027 (USD MILLION)
                                              TABLE 131 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR BIOSYNTHESIS, BY COUNTRY,  2020–2027 (USD MILLION)
                    8.2.3.2 Stem cell regulation
                               8.2.3.2.1 Increased use of synthetic biology in stem cell regeneration  and reprogramming somatic cells to drive  market
                                              TABLE 132 SYNTHETIC BIOLOGY MARKET FOR STEM CELL REGULATION, BY REGION,  2020–2027 (USD MILLION)
                                              TABLE 133 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR STEM CELL REGULATION, BY COUNTRY, 2020–2027 (USD MILLION)
                                              TABLE 134 EUROPE: SYNTHETIC BIOLOGY MARKET FOR STEM CELL REGULATION, BY COUNTRY, 2020–2027 (USD MILLION)
                                              TABLE 135 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR STEM CELL REGULATION, BY COUNTRY, 2020–2027 (USD MILLION)
                                              TABLE 136 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR STEM CELL REGULATION,  BY COUNTRY, 2020–2027 (USD MILLION)
                    8.2.3.3 Other artificial tissue and tissue regeneration applications
                                TABLE 137 SYNTHETIC BIOLOGY MARKET FOR OTHER ARTIFICIAL TISSUE AND TISSUE REGENERATION APPLICATIONS, BY REGION, 2020–2027 (USD MILLION)
                                TABLE 138 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR OTHER ARTIFICIAL TISSUE AND TISSUE REGENERATION APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION)
                                TABLE 139 EUROPE: SYNTHETIC BIOLOGY MARKET FOR OTHER ARTIFICIAL TISSUE AND TISSUE REGENERATION APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION)
                                TABLE 140 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR OTHER ARTIFICIAL TISSUE AND TISSUE REGENERATION APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION)
                                TABLE 141 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR OTHER ARTIFICIAL TISSUE AND TISSUE REGENERATION APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION)
    8.3 INDUSTRIAL APPLICATIONS 
          TABLE 142 SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL APPLICATIONS, BY TYPE,  2020–2027 (USD MILLION)
          TABLE 143 SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL APPLICATIONS, BY REGION,  2020–2027 (USD MILLION)
          TABLE 144 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL APPLICATIONS,  BY COUNTRY, 2020–2027 (USD MILLION)
          TABLE 145 EUROPE: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION)
          TABLE 146 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL APPLICATIONS,  BY COUNTRY, 2020–2027 (USD MILLION)
          TABLE 147 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL APPLICATIONS,  BY COUNTRY, 2020–2027 (USD MILLION)
           8.3.1 BIOFUEL AND RENEWABLE ENERGY
                    8.3.1.1 Advantages of using genetically engineered organisms for synthetic production of biofuels to support market
                                TABLE 148 SYNTHETIC BIOLOGY MARKET FOR BIOFUEL AND RENEWABLE ENERGY, BY REGION,  2020–2027 (USD MILLION)
                                TABLE 149 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR BIOFUEL AND RENEWABLE ENERGY, BY COUNTRY, 2020–2027 (USD MILLION)
                                TABLE 150 EUROPE: SYNTHETIC BIOLOGY MARKET FOR BIOFUEL AND RENEWABLE ENERGY,  BY COUNTRY, 2020–2027 (USD MILLION)
                                TABLE 151 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR BIOFUEL AND RENEWABLE ENERGY, BY COUNTRY, 2020–2027 (USD MILLION)
                                TABLE 152 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR BIOFUEL AND RENEWABLE ENERGY, BY COUNTRY, 2020–2027 (USD MILLION)
           8.3.2 INDUSTRIAL ENZYMES
                    TABLE 153 SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL ENZYMES, BY INDUSTRY,  2020–2027 (USD MILLION)
                    TABLE 154 SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL ENZYMES, BY REGION,  2020–2027 (USD MILLION)
                    TABLE 155 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL ENZYMES, BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 156 EUROPE: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL ENZYMES, BY COUNTRY,  2020–2027 (USD MILLION)
                    TABLE 157 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL ENZYMES, BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 158 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL ENZYMES, BY COUNTRY, 2020–2027 (USD MILLION)
                    8.3.2.1 Textile industry
                               8.3.2.1.1 Synthetic biology to replace traditional raw materials in textile industry
                                              TABLE 159 SYNTHETIC BIOLOGY MARKET FOR TEXTILE INDUSTRY, BY REGION,  2020–2027 (USD MILLION)
                                              TABLE 160 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR TEXTILE INDUSTRY, BY COUNTRY, 2020–2027 (USD MILLION)
                                              TABLE 161 EUROPE: SYNTHETIC BIOLOGY MARKET FOR TEXTILE INDUSTRY, BY COUNTRY,  2020–2027 (USD MILLION)
                                              TABLE 162 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR TEXTILE INDUSTRY, BY COUNTRY,  2020–2027 (USD MILLION)
                                              TABLE 163 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR TEXTILE INDUSTRY, BY COUNTRY, 2020–2027 (USD MILLION)
                    8.3.2.2 Paper industry
                               8.3.2.2.1 Increasing use of enzymes in pulp and  paper industry to favor market growth
                                              TABLE 164 SYNTHETIC BIOLOGY MARKET FOR PAPER INDUSTRY, BY REGION,  2020–2027 (USD MILLION)
                                              TABLE 165 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR PAPER INDUSTRY, BY COUNTRY, 2020–2027 (USD MILLION)
                                              TABLE 166 EUROPE: SYNTHETIC BIOLOGY MARKET FOR PAPER INDUSTRY, BY COUNTRY,  2020–2027 (USD MILLION)
                                              TABLE 167 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR PAPER INDUSTRY, BY COUNTRY,  2020–2027 (USD MILLION)
                                              TABLE 168 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR PAPER INDUSTRY, BY COUNTRY, 2020–2027 (USD MILLION)
                    8.3.2.3 Consumer care industry
                                TABLE 169 SYNTHETIC BIOLOGY MARKET FOR CONSUMER CARE INDUSTRY, BY TYPE,  2020–2027 (USD MILLION)
                                TABLE 170 SYNTHETIC BIOLOGY MARKET FOR CONSUMER CARE INDUSTRY, BY REGION,  2020–2027 (USD MILLION)
                                TABLE 171 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR CONSUMER CARE INDUSTRY,  BY COUNTRY, 2020–2027 (USD MILLION)
                                TABLE 172 EUROPE: SYNTHETIC BIOLOGY MARKET FOR CONSUMER CARE INDUSTRY, BY COUNTRY, 2020–2027 (USD MILLION)
                                TABLE 173 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR CONSUMER CARE INDUSTRY,  BY COUNTRY, 2020–2027 (USD MILLION)
                                TABLE 174 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR CONSUMER CARE INDUSTRY,  BY COUNTRY, 2020–2027 (USD MILLION)
                               8.3.2.3.1 Cosmetics
                                             8.3.2.3.1.1 Increased use of synthetic biology techniques for development of skincare and cosmetics to propel market
                                                              TABLE 175 SYNTHETIC BIOLOGY MARKET FOR SKINCARE AND COSMETICS, BY REGION,  2020–2027 (USD MILLION)
                                                              TABLE 176 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR SKINCARE AND COSMETICS,  BY COUNTRY, 2020–2027 (USD MILLION)
                                                              TABLE 177 EUROPE: SYNTHETIC BIOLOGY MARKET FOR SKINCARE AND COSMETICS, BY COUNTRY, 2020–2027 (USD MILLION)
                                                              TABLE 178 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR SKINCARE AND COSMETICS,  BY COUNTRY, 2020–2027 (USD MILLION)
                                                              TABLE 179 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR SKINCARE AND COSMETICS,  BY COUNTRY, 2020–2027 (USD MILLION)
                               8.3.2.3.2 Other consumer care products
                                              TABLE 180 SYNTHETIC BIOLOGY MARKET FOR OTHER CONSUMER CARE PRODUCTS, BY REGION,  2020–2027 (USD MILLION)
                                              TABLE 181 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR OTHER CONSUMER CARE PRODUCTS, BY COUNTRY, 2020–2027 (USD MILLION)
                                              TABLE 182 EUROPE: SYNTHETIC BIOLOGY MARKET FOR OTHER CONSUMER CARE PRODUCTS,  BY COUNTRY, 2020–2027 (USD MILLION)
                                              TABLE 183 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR OTHER CONSUMER CARE PRODUCTS, BY COUNTRY, 2020–2027 (USD MILLION)
                                              TABLE 184 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR OTHER CONSUMER CARE PRODUCTS, BY COUNTRY, 2020–2027 (USD MILLION)
                    8.3.2.4 Other industries
                                TABLE 185 SYNTHETIC BIOLOGY MARKET FOR OTHER INDUSTRIES, BY REGION,  2020–2027 (USD MILLION)
                                TABLE 186 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR OTHER INDUSTRIES, BY COUNTRY, 2020–2027 (USD MILLION)
                                TABLE 187 EUROPE: SYNTHETIC BIOLOGY MARKET FOR OTHER INDUSTRIES, BY COUNTRY, 2020–2027 (USD MILLION)
                                TABLE 188 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR OTHER INDUSTRIES, BY COUNTRY, 2020–2027 (USD MILLION)
                                TABLE 189 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR OTHER INDUSTRIES, BY COUNTRY, 2020–2027 (USD MILLION)
           8.3.3 BIOMATERIALS AND GREEN CHEMICALS
                    8.3.3.1 Use of synthetic biology for preparing silk-based proteins to support market
                                TABLE 190 SYNTHETIC BIOLOGY MARKET FOR BIOMATERIALS AND GREEN CHEMICALS, BY REGION,  2020–2027 (USD MILLION)
                                TABLE 191 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR BIOMATERIALS AND GREEN CHEMICALS, BY COUNTRY, 2020–2027 (USD MILLION)
                                TABLE 192 EUROPE: SYNTHETIC BIOLOGY MARKET FOR BIOMATERIALS AND GREEN CHEMICALS,  BY COUNTRY, 2020–2027 (USD MILLION)
                                TABLE 193 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR BIOMATERIALS AND GREEN CHEMICALS, BY COUNTRY, 2020–2027 (USD MILLION)
                                TABLE 194 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR BIOMATERIALS AND GREEN CHEMICALS, BY COUNTRY, 2020–2027 (USD MILLION)
    8.4 FOOD AND AGRICULTURAL APPLICATIONS 
          TABLE 195 SYNTHETIC BIOLOGY MARKET FOR FOOD AND AGRICULTURAL APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)
          TABLE 196 SYNTHETIC BIOLOGY MARKET FOR FOOD AND AGRICULTURAL APPLICATIONS, BY REGION,  2020–2027 (USD MILLION)
          TABLE 197 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR FOOD AND AGRICULTURAL APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION)
          TABLE 198 EUROPE: SYNTHETIC BIOLOGY MARKET FOR FOOD AND AGRICULTURAL APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION)
          TABLE 199 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR FOOD AND AGRICULTURAL APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION)
          TABLE 200 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR FOOD AND AGRICULTURAL APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION)
           8.4.1 FLAVORS AND FRAGRANCES
                    8.4.1.1 Manufactured using engineered microbes
                                TABLE 201 SYNTHETIC BIOLOGY MARKET FOR FLAVORS AND FRAGRANCES, BY REGION,  2020–2027 (USD MILLION)
                                TABLE 202 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR FLAVORS AND FRAGRANCES,  BY COUNTRY, 2020–2027 (USD MILLION)
                                TABLE 203 EUROPE: SYNTHETIC BIOLOGY MARKET FOR FLAVORS AND FRAGRANCES, BY COUNTRY, 2020–2027 (USD MILLION)
                                TABLE 204 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR FLAVORS AND FRAGRANCES,  BY COUNTRY, 2020–2027 (USD MILLION)
                                TABLE 205 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR FLAVORS AND FRAGRANCES,  BY COUNTRY, 2020–2027 (USD MILLION)
           8.4.2 OTHER FOOD AND AGRICULTURAL APPLICATIONS
                    TABLE 206 SYNTHETIC BIOLOGY MARKET FOR OTHER FOOD AND AGRICULTURAL APPLICATIONS,  BY REGION, 2020–2027 (USD MILLION)
                    TABLE 207 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR OTHER FOOD AND AGRICULTURAL APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 208 EUROPE: SYNTHETIC BIOLOGY MARKET FOR OTHER FOOD AND AGRICULTURAL APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 209 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR OTHER FOOD AND AGRICULTURAL APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 210 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR OTHER FOOD AND AGRICULTURAL APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION)
    8.5 ENVIRONMENTAL APPLICATIONS 
          TABLE 211 SYNTHETIC BIOLOGY MARKET FOR ENVIRONMENTAL APPLICATIONS, BY TYPE,  2020–2027 (USD MILLION)
          TABLE 212 SYNTHETIC BIOLOGY MARKET FOR ENVIRONMENTAL APPLICATIONS, BY REGION,  2020–2027 (USD MILLION)
          TABLE 213 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR ENVIRONMENTAL APPLICATIONS,  BY COUNTRY, 2020–2027 (USD MILLION)
          TABLE 214 EUROPE: SYNTHETIC BIOLOGY MARKET FOR ENVIRONMENTAL APPLICATIONS,  BY COUNTRY, 2020–2027 (USD MILLION)
          TABLE 215 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR ENVIRONMENTAL APPLICATIONS,  BY COUNTRY, 2020–2027 (USD MILLION)
          TABLE 216 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR ENVIRONMENTAL APPLICATIONS,  BY COUNTRY, 2020–2027 (USD MILLION)
           8.5.1 BIOREMEDIATION
                    8.5.1.1 Bioremediation helps in cleaning oil spills, preventing chemical pollution, and plugging nuclear leakages
                                TABLE 217 SYNTHETIC BIOLOGY MARKET FOR BIOREMEDIATION, BY REGION,  2020–2027 (USD MILLION)
                                TABLE 218 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR BIOREMEDIATION, BY COUNTRY, 2020–2027 (USD MILLION)
                                TABLE 219 EUROPE: SYNTHETIC BIOLOGY MARKET FOR BIOREMEDIATION, BY COUNTRY,  2020–2027 (USD MILLION)
                                TABLE 220 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR BIOREMEDIATION, BY COUNTRY,  2020–2027 (USD MILLION)
                                TABLE 221 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR BIOREMEDIATION, BY COUNTRY, 2020–2027 (USD MILLION)
           8.5.2 BIOSENSING
                    8.5.2.1 Biosensors utilize microalgae due to high reproductive rates and ease of culturing
                                TABLE 222 SYNTHETIC BIOLOGY MARKET FOR BIOSENSING, BY REGION,  2020–2027 (USD MILLION)
                                TABLE 223 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR BIOSENSING, BY COUNTRY,  2020–2027 (USD MILLION)
                                TABLE 224 EUROPE: SYNTHETIC BIOLOGY MARKET FOR BIOSENSING, BY COUNTRY,  2020–2027 (USD MILLION)
                                TABLE 225 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR BIOSENSING, BY COUNTRY,  2020–2027 (USD MILLION)
                                TABLE 226 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR BIOSENSING, BY COUNTRY,  2020–2027 (USD MILLION)
 
9 SYNTHETIC BIOLOGY MARKET, BY REGION (Page No. - 231)
    9.1 INTRODUCTION 
          TABLE 227 SYNTHETIC BIOLOGY MARKET, BY REGION, 2020–2027 (USD MILLION)
    9.2 NORTH AMERICA 
          FIGURE 20 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET SNAPSHOT
          TABLE 228 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET, BY COUNTRY,  2020–2027 (USD MILLION)
          TABLE 229 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET, BY TOOL, 2020–2027 (USD MILLION)
          TABLE 230 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET, BY TECHNOLOGY,  2020–2027 (USD MILLION)
          TABLE 231 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET, BY APPLICATION,  2020–2027 (USD MILLION)
          TABLE 232 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)
          TABLE 233 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR DRUG DISCOVERY AND THERAPEUTICS, BY TYPE, 2020–2027 (USD MILLION)
          TABLE 234 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR ARTIFICIAL TISSUE AND TISSUE REGENERATION, BY TYPE, 2020–2027 (USD MILLION)
          TABLE 235 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL APPLICATIONS,  BY TYPE, 2020–2027 (USD MILLION)
          TABLE 236 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL ENZYMES,  BY INDUSTRY, 2020–2027 (USD MILLION)
          TABLE 237 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR CONSUMER CARE INDUSTRY,  BY TYPE, 2020–2027 (USD MILLION)
          TABLE 238 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR ENVIRONMENTAL APPLICATIONS,  BY TYPE, 2020–2027 (USD MILLION)
          TABLE 239 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR FOOD AND AGRICULTURAL APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)
           9.2.1 US
                    9.2.1.1 US accounts for highest number of studies carried out on synthetic biology globally
                                TABLE 240 US: SYNTHETIC BIOLOGY MARKET, BY TOOL, 2020–2027 (USD MILLION)
                                TABLE 241 US: SYNTHETIC BIOLOGY MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)
                                TABLE 242 US: SYNTHETIC BIOLOGY MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
                                TABLE 243 US: SYNTHETIC BIOLOGY MARKET FOR MEDICAL APPLICATIONS, BY TYPE,  2020–2027 (USD MILLION)
                                TABLE 244 US: SYNTHETIC BIOLOGY MARKET FOR DRUG DISCOVERY AND THERAPEUTICS, BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 245 US: SYNTHETIC BIOLOGY MARKET FOR ARTIFICIAL TISSUE AND TISSUE REGENERATION, BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 246 US: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL APPLICATIONS, BY TYPE,  2020–2027 (USD MILLION)
                                TABLE 247 US: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL ENZYMES, BY INDUSTRY,  2020–2027 (USD MILLION)
                                TABLE 248 US: SYNTHETIC BIOLOGY MARKET FOR CONSUMER CARE INDUSTRY, BY TYPE,  2020–2027 (USD MILLION)
                                TABLE 249 US: SYNTHETIC BIOLOGY MARKET FOR ENVIRONMENTAL APPLICATIONS, BY TYPE,  2020–2027 (USD MILLION)
                                TABLE 250 US: SYNTHETIC BIOLOGY MARKET FOR FOOD AND AGRICULTURAL APPLICATIONS,  BY TYPE, 2020–2027 (USD MILLION)
           9.2.2 CANADA
                    9.2.2.1 Strong research infrastructure and availability of funding to support market
                                TABLE 251 CANADA: SYNTHETIC BIOLOGY MARKET, BY TOOL, 2020–2027 (USD MILLION)
                                TABLE 252 CANADA: SYNTHETIC BIOLOGY MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)
                                TABLE 253 CANADA: SYNTHETIC BIOLOGY MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
                                TABLE 254 CANADA: SYNTHETIC BIOLOGY MARKET FOR MEDICAL APPLICATIONS, BY TYPE,  2020–2027 (USD MILLION)
                                TABLE 255 CANADA: SYNTHETIC BIOLOGY MARKET FOR DRUG DISCOVERY AND THERAPEUTICS,  BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 256 CANADA: SYNTHETIC BIOLOGY MARKET FOR ARTIFICIAL TISSUE AND TISSUE REGENERATION, BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 257 CANADA: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL APPLICATIONS, BY TYPE,  2020–2027 (USD MILLION)
                                TABLE 258 CANADA: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL ENZYMES, BY INDUSTRY,  2020–2027 (USD MILLION)
                                TABLE 259 CANADA: SYNTHETIC BIOLOGY MARKET FOR CONSUMER CARE INDUSTRY, BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 260 CANADA: SYNTHETIC BIOLOGY MARKET FOR ENVIRONMENTAL APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 261 CANADA: SYNTHETIC BIOLOGY MARKET FOR FOOD AND AGRICULTURAL APPLICATIONS,  BY TYPE, 2020–2027 (USD MILLION)
           9.2.3 RECESSION IMPACT
    9.3 EUROPE 
          TABLE 262 EUROPE: SYNTHETIC BIOLOGY MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
          TABLE 263 EUROPE: SYNTHETIC BIOLOGY MARKET, BY TOOL, 2020–2027 (USD MILLION)
          TABLE 264 EUROPE: SYNTHETIC BIOLOGY MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)
          TABLE 265 EUROPE: SYNTHETIC BIOLOGY MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
          TABLE 266 EUROPE: SYNTHETIC BIOLOGY MARKET FOR MEDICAL APPLICATIONS, BY TYPE,  2020–2027 (USD MILLION)
          TABLE 267 EUROPE: SYNTHETIC BIOLOGY MARKET FOR DRUG DISCOVERY AND THERAPEUTICS,  BY TYPE, 2020–2027 (USD MILLION)
          TABLE 268 EUROPE: SYNTHETIC BIOLOGY MARKET FOR ARTIFICIAL TISSUE AND TISSUE REGENERATION, BY TYPE, 2020–2027 (USD MILLION)
          TABLE 269 EUROPE: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL APPLICATIONS, BY TYPE,  2020–2027 (USD MILLION)
          TABLE 270 EUROPE: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL ENZYMES, BY INDUSTRY,  2020–2027 (USD MILLION)
          TABLE 271 EUROPE: SYNTHETIC BIOLOGY MARKET FOR CONSUMER CARE INDUSTRY, BY TYPE, 2020–2027 (USD MILLION)
          TABLE 272 EUROPE: SYNTHETIC BIOLOGY MARKET FOR ENVIRONMENTAL APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)
          TABLE 273 EUROPE: SYNTHETIC BIOLOGY MARKET FOR FOOD AND AGRICULTURAL APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)
           9.3.1 GERMANY
                    9.3.1.1 Rapidly growing pharmaceutical market to drive market
                                TABLE 274 GERMANY: SYNTHETIC BIOLOGY MARKET, BY TOOL, 2020–2027 (USD MILLION)
                                TABLE 275 GERMANY: SYNTHETIC BIOLOGY MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)
                                TABLE 276 GERMANY: SYNTHETIC BIOLOGY MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
                                TABLE 277 GERMANY: SYNTHETIC BIOLOGY MARKET FOR MEDICAL APPLICATIONS, BY TYPE,  2020–2027 (USD MILLION)
                                TABLE 278 GERMANY: SYNTHETIC BIOLOGY MARKET FOR DRUG DISCOVERY AND THERAPEUTICS,  BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 279 GERMANY: SYNTHETIC BIOLOGY MARKET FOR ARTIFICIAL TISSUE AND TISSUE REGENERATION, BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 280 GERMANY: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 281 GERMANY: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL ENZYMES, BY INDUSTRY, 2020–2027 (USD MILLION)
                                TABLE 282 GERMANY: SYNTHETIC BIOLOGY MARKET FOR CONSUMER CARE INDUSTRY, BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 283 GERMANY: SYNTHETIC BIOLOGY MARKET FOR ENVIRONMENTAL APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 284 GERMANY: SYNTHETIC BIOLOGY MARKET FOR FOOD AND AGRICULTURAL APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)
           9.3.2 UK
                    9.3.2.1 Increasing R&D expenditure to favor market
                                TABLE 285 UK: SYNTHETIC BIOLOGY MARKET, BY TOOL, 2020–2027 (USD MILLION)
                                TABLE 286 UK: SYNTHETIC BIOLOGY MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)
                                TABLE 287 UK: SYNTHETIC BIOLOGY MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
                                TABLE 288 UK: SYNTHETIC BIOLOGY MARKET FOR MEDICAL APPLICATIONS, BY TYPE,  2020–2027 (USD MILLION)
                                TABLE 289 UK: SYNTHETIC BIOLOGY MARKET FOR DRUG DISCOVERY AND THERAPEUTICS, BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 290 UK: SYNTHETIC BIOLOGY MARKET FOR ARTIFICIAL TISSUE AND TISSUE REGENERATION, BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 291 UK: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL APPLICATIONS, BY TYPE,  2020–2027 (USD MILLION)
                                TABLE 292 UK: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL ENZYMES, BY INDUSTRY,  2020–2027 (USD MILLION)
                                TABLE 293 UK: SYNTHETIC BIOLOGY MARKET FOR CONSUMER CARE INDUSTRY, BY TYPE,  2020–2027 (USD MILLION)
                                TABLE 294 UK: SYNTHETIC BIOLOGY MARKET FOR ENVIRONMENTAL APPLICATIONS,  BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 295 UK: SYNTHETIC BIOLOGY MARKET FOR FOOD AND AGRICULTURAL APPLICATIONS,  BY TYPE, 2020–2027 (USD MILLION)
           9.3.3 FRANCE
                    9.3.3.1 Availability of funds from government and private organizations for domestic drug development to support market
                                TABLE 296 FRANCE: SYNTHETIC BIOLOGY MARKET, BY TOOL, 2020–2027 (USD MILLION)
                                TABLE 297 FRANCE: SYNTHETIC BIOLOGY MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)
                                TABLE 298 FRANCE: SYNTHETIC BIOLOGY MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
                                TABLE 299 FRANCE: SYNTHETIC BIOLOGY MARKET FOR MEDICAL APPLICATIONS, BY TYPE,  2020–2027 (USD MILLION)
                                TABLE 300 FRANCE: SYNTHETIC BIOLOGY MARKET FOR DRUG DISCOVERY AND THERAPEUTICS,  BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 301 FRANCE: SYNTHETIC BIOLOGY MARKET FOR ARTIFICIAL TISSUE AND TISSUE REGENERATION, BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 302 FRANCE: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL APPLICATIONS,  BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 303 FRANCE: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL ENZYMES, BY INDUSTRY,  2020–2027 (USD MILLION)
                                TABLE 304 FRANCE: SYNTHETIC BIOLOGY MARKET FOR CONSUMER CARE INDUSTRY, BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 305 FRANCE: SYNTHETIC BIOLOGY MARKET FOR ENVIRONMENTAL APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 306 FRANCE: SYNTHETIC BIOLOGY MARKET FOR FOOD AND AGRICULTURAL APPLICATIONS,  BY TYPE, 2020–2027 (USD MILLION)
           9.3.4 SWITZERLAND
                    9.3.4.1 Well-established pharmaceutical and biotechnology industry to favor market
                                TABLE 307 SWITZERLAND: SYNTHETIC BIOLOGY MARKET, BY TOOL, 2020–2027 (USD MILLION)
                                TABLE 308 SWITZERLAND: SYNTHETIC BIOLOGY MARKET, BY TECHNOLOGY,  2020–2027 (USD MILLION)
                                TABLE 309 SWITZERLAND: SYNTHETIC BIOLOGY MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
                                TABLE 310 SWITZERLAND: SYNTHETIC BIOLOGY MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 311 SWITZERLAND: SYNTHETIC BIOLOGY MARKET FOR DRUG DISCOVERY AND THERAPEUTICS, BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 312 SWITZERLAND: SYNTHETIC BIOLOGY MARKET FOR ARTIFICIAL TISSUE AND TISSUE REGENERATION, BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 313 SWITZERLAND: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 314 SWITZERLAND: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL ENZYMES, BY INDUSTRY, 2020–2027 (USD MILLION)
                                TABLE 315 SWITZERLAND: SYNTHETIC BIOLOGY MARKET FOR CONSUMER CARE INDUSTRY, BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 316 SWITZERLAND: SYNTHETIC BIOLOGY MARKET FOR ENVIRONMENTAL APPLICATIONS,  BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 317 SWITZERLAND: SYNTHETIC BIOLOGY MARKET FOR FOOD AND AGRICULTURAL APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)
           9.3.5 DENMARK
                    9.3.5.1 Third-largest commercial drug development pipeline in Europe to drive market
                                TABLE 318 DENMARK: SYNTHETIC BIOLOGY MARKET, BY TOOL, 2020–2027 (USD MILLION)
                                TABLE 319 DENMARK: SYNTHETIC BIOLOGY MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)
                                TABLE 320 DENMARK: SYNTHETIC BIOLOGY MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
                                TABLE 321 DENMARK: SYNTHETIC BIOLOGY MARKET FOR MEDICAL APPLICATIONS, BY TYPE,  2020–2027 (USD MILLION)
                                TABLE 322 DENMARK: SYNTHETIC BIOLOGY MARKET FOR DRUG DISCOVERY AND THERAPEUTICS,  BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 323 DENMARK: SYNTHETIC BIOLOGY MARKET FOR ARTIFICIAL TISSUE AND TISSUE REGENERATION, BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 324 DENMARK: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 325 DENMARK: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL ENZYMES, BY INDUSTRY, 2020–2027 (USD MILLION)
                                TABLE 326 DENMARK: SYNTHETIC BIOLOGY MARKET FOR CONSUMER CARE INDUSTRY, BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 327 DENMARK: SYNTHETIC BIOLOGY MARKET FOR ENVIRONMENTAL APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 328 DENMARK: SYNTHETIC BIOLOGY MARKET FOR FOOD AND AGRICULTURAL APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)
           9.3.6 ITALY
                    9.3.6.1 Increasing life science R&D, funded by both public and private organizations, to drive market
                                TABLE 329 ITALY: SYNTHETIC BIOLOGY MARKET, BY TOOL, 2020–2027 (USD MILLION)
                                TABLE 330 ITALY: SYNTHETIC BIOLOGY MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)
                                TABLE 331 ITALY: SYNTHETIC BIOLOGY MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
                                TABLE 332 ITALY: SYNTHETIC BIOLOGY MARKET FOR MEDICAL APPLICATIONS, BY TYPE,  2020–2027 (USD MILLION)
                                TABLE 333 ITALY: SYNTHETIC BIOLOGY MARKET FOR DRUG DISCOVERY AND THERAPEUTICS, BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 334 ITALY: SYNTHETIC BIOLOGY MARKET FOR ARTIFICIAL TISSUE AND TISSUE REGENERATION, BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 335 ITALY: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL APPLICATIONS, BY TYPE,  2020–2027 (USD MILLION)
                                TABLE 336 ITALY: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL ENZYMES, BY INDUSTRY, 2020–2027 (USD MILLION)
                                TABLE 337 ITALY: SYNTHETIC BIOLOGY MARKET FOR CONSUMER CARE INDUSTRY, BY TYPE,  2020–2027 (USD MILLION)
                                TABLE 338 ITALY: SYNTHETIC BIOLOGY MARKET FOR ENVIRONMENTAL APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 339 ITALY: SYNTHETIC BIOLOGY MARKET FOR FOOD AND AGRICULTURAL APPLICATIONS,  BY TYPE, 2020–2027 (USD MILLION)
           9.3.7 SPAIN
                    9.3.7.1 Well-established network of research centers, universities, and hospitals to support market
                                TABLE 340 SPAIN: SYNTHETIC BIOLOGY MARKET, BY TOOL, 2020–2027 (USD MILLION)
                                TABLE 341 SPAIN: SYNTHETIC BIOLOGY MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)
                                TABLE 342 SPAIN: SYNTHETIC BIOLOGY MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
                                TABLE 343 SPAIN: SYNTHETIC BIOLOGY MARKET FOR MEDICAL APPLICATIONS, BY TYPE,  2020–2027 (USD MILLION)
                                TABLE 344 SPAIN: SYNTHETIC BIOLOGY MARKET FOR DRUG DISCOVERY AND THERAPEUTICS,  BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 345 SPAIN: SYNTHETIC BIOLOGY MARKET FOR ARTIFICIAL TISSUE AND TISSUE REGENERATION, BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 346 SPAIN: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL APPLICATIONS, BY TYPE,  2020–2027 (USD MILLION)
                                TABLE 347 SPAIN: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL ENZYMES, BY INDUSTRY,  2020–2027 (USD MILLION)
                                TABLE 348 SPAIN: SYNTHETIC BIOLOGY MARKET FOR CONSUMER CARE INDUSTRY, BY TYPE,  2020–2027 (USD MILLION)
                                TABLE 349 SPAIN: SYNTHETIC BIOLOGY MARKET FOR ENVIRONMENTAL APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 350 SPAIN: SYNTHETIC BIOLOGY MARKET FOR FOOD AND AGRICULTURAL APPLICATIONS,  BY TYPE, 2020–2027 (USD MILLION)
           9.3.8 REST OF EUROPE
                    TABLE 351 REST OF EUROPE: SYNTHETIC BIOLOGY MARKET, BY TOOL, 2020–2027 (USD MILLION)
                    TABLE 352 REST OF EUROPE: SYNTHETIC BIOLOGY MARKET, BY TECHNOLOGY,  2020–2027 (USD MILLION)
                    TABLE 353 REST OF EUROPE: SYNTHETIC BIOLOGY MARKET, BY APPLICATION,  2020–2027 (USD MILLION)
                    TABLE 354 REST OF EUROPE: SYNTHETIC BIOLOGY MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)
                    TABLE 355 REST OF EUROPE: SYNTHETIC BIOLOGY MARKET FOR DRUG DISCOVERY AND THERAPEUTICS, BY TYPE, 2020–2027 (USD MILLION)
                    TABLE 356 REST OF EUROPE: SYNTHETIC BIOLOGY MARKET FOR ARTIFICIAL TISSUE AND TISSUE REGENERATION, BY TYPE, 2020–2027 (USD MILLION)
                    TABLE 357 REST OF EUROPE: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL APPLICATIONS,  BY TYPE, 2020–2027 (USD MILLION)
                    TABLE 358 REST OF EUROPE: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL ENZYMES,  BY INDUSTRY, 2020–2027 (USD MILLION)
                    TABLE 359 REST OF EUROPE: SYNTHETIC BIOLOGY MARKET FOR CONSUMER CARE INDUSTRY,  BY TYPE, 2020–2027 (USD MILLION)
                    TABLE 360 REST OF EUROPE: SYNTHETIC BIOLOGY MARKET FOR ENVIRONMENTAL APPLICATIONS,  BY TYPE, 2020–2027 (USD MILLION)
                    TABLE 361 REST OF EUROPE: SYNTHETIC BIOLOGY MARKET FOR FOOD AND AGRICULTURAL APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)
           9.3.9 RECESSION IMPACT
    9.4 ASIA PACIFIC 
          FIGURE 21 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET SNAPSHOT
          TABLE 362 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
          TABLE 363 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET, BY TOOL, 2020–2027 (USD MILLION)
          TABLE 364 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET, BY TECHNOLOGY,  2020–2027 (USD MILLION)
          TABLE 365 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET, BY APPLICATION,  2020–2027 (USD MILLION)
          TABLE 366 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)
          TABLE 367 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR DRUG DISCOVERY AND THERAPEUTICS, BY TYPE, 2020–2027 (USD MILLION)
          TABLE 368 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR ARTIFICIAL TISSUE AND TISSUE REGENERATION, BY TYPE, 2020–2027 (USD MILLION)
          TABLE 369 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)
          TABLE 370 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL ENZYMES, BY INDUSTRY, 2020–2027 (USD MILLION)
          TABLE 371 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR CONSUMER CARE INDUSTRY, BY TYPE, 2020–2027 (USD MILLION)
          TABLE 372 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR ENVIRONMENTAL APPLICATIONS,  BY TYPE, 2020–2027 (USD MILLION)
          TABLE 373 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR FOOD AND AGRICULTURAL APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)
           9.4.1 CHINA
                    9.4.1.1 Growing R&D to enhance technological capabilities to favor market
                                TABLE 374 CHINA: SYNTHETIC BIOLOGY MARKET, BY TOOL, 2020–2027 (USD MILLION)
                                TABLE 375 CHINA: SYNTHETIC BIOLOGY MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)
                                TABLE 376 CHINA: SYNTHETIC BIOLOGY MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
                                TABLE 377 CHINA: SYNTHETIC BIOLOGY MARKET FOR MEDICAL APPLICATIONS, BY TYPE,  2020–2027 (USD MILLION)
                                TABLE 378 CHINA: SYNTHETIC BIOLOGY MARKET FOR DRUG DISCOVERY AND THERAPEUTICS,  BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 379 CHINA: SYNTHETIC BIOLOGY MARKET FOR ARTIFICIAL TISSUE AND TISSUE REGENERATION, BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 380 CHINA: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL APPLICATIONS, BY TYPE,  2020–2027 (USD MILLION)
                                TABLE 381 CHINA: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL ENZYMES, BY INDUSTRY,  2020–2027 (USD MILLION)
                                TABLE 382 CHINA: SYNTHETIC BIOLOGY MARKET FOR CONSUMER CARE INDUSTRY, BY TYPE,  2020–2027 (USD MILLION)
                                TABLE 383 CHINA: SYNTHETIC BIOLOGY MARKET FOR ENVIRONMENTAL APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 384 CHINA: SYNTHETIC BIOLOGY MARKET FOR FOOD AND AGRICULTURAL APPLICATIONS,  BY TYPE, 2020–2027 (USD MILLION)
           9.4.2 JAPAN
                    9.4.2.1 Large number of research initiatives for development of precision medicine to support market
                                TABLE 385 JAPAN: SYNTHETIC BIOLOGY MARKET, BY TOOL, 2020–2027 (USD MILLION)
                                TABLE 386 JAPAN: SYNTHETIC BIOLOGY MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)
                                TABLE 387 JAPAN: SYNTHETIC BIOLOGY MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
                                TABLE 388 JAPAN: SYNTHETIC BIOLOGY MARKET FOR MEDICAL APPLICATIONS, BY TYPE,  2020–2027 (USD MILLION)
                                TABLE 389 JAPAN: SYNTHETIC BIOLOGY MARKET FOR DRUG DISCOVERY AND THERAPEUTICS,  BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 390 JAPAN: SYNTHETIC BIOLOGY MARKET FOR ARTIFICIAL TISSUE AND TISSUE REGENERATION, BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 391 JAPAN: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL APPLICATIONS, BY TYPE,  2020–2027 (USD MILLION)
                                TABLE 392 JAPAN: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL ENZYMES, BY INDUSTRY,  2020–2027 (USD MILLION)
                                TABLE 393 JAPAN: SYNTHETIC BIOLOGY MARKET FOR CONSUMER CARE INDUSTRY, BY TYPE,  2020–2027 (USD MILLION)
                                TABLE 394 JAPAN: SYNTHETIC BIOLOGY MARKET FOR ENVIRONMENTAL APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 395 JAPAN: SYNTHETIC BIOLOGY MARKET FOR FOOD AND AGRICULTURAL APPLICATIONS,  BY TYPE, 2020–2027 (USD MILLION)
           9.4.3 AUSTRALIA
                    9.4.3.1 Increasing focus of healthcare system on precision medicine to offer significant growth opportunities
                                TABLE 396 AUSTRALIA: SYNTHETIC BIOLOGY MARKET, BY TOOL, 2020–2027 (USD MILLION)
                                TABLE 397 AUSTRALIA: SYNTHETIC BIOLOGY MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)
                                TABLE 398 AUSTRALIA: SYNTHETIC BIOLOGY MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
                                TABLE 399 AUSTRALIA: SYNTHETIC BIOLOGY MARKET FOR MEDICAL APPLICATIONS, BY TYPE,  2020–2027 (USD MILLION)
                                TABLE 400 AUSTRALIA: SYNTHETIC BIOLOGY MARKET FOR DRUG DISCOVERY AND THERAPEUTICS,  BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 401 AUSTRALIA: SYNTHETIC BIOLOGY MARKET FOR ARTIFICIAL TISSUE AND TISSUE REGENERATION, BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 402 AUSTRALIA: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 403 AUSTRALIA: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL ENZYMES, BY INDUSTRY, 2020–2027 (USD MILLION)
                                TABLE 404 AUSTRALIA: SYNTHETIC BIOLOGY MARKET FOR CONSUMER CARE INDUSTRY, BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 405 AUSTRALIA: SYNTHETIC BIOLOGY MARKET FOR ENVIRONMENTAL APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 406 AUSTRALIA: SYNTHETIC BIOLOGY MARKET FOR FOOD AND AGRICULTURAL APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)
           9.4.4 INDIA
                    9.4.4.1 Increasing pharma R&D activities and government funding for biotechnology industry to support market
                                TABLE 407 INDIA: SYNTHETIC BIOLOGY MARKET, BY TOOL, 2020–2027 (USD MILLION)
                                TABLE 408 INDIA: SYNTHETIC BIOLOGY MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)
                                TABLE 409 INDIA: SYNTHETIC BIOLOGY MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
                                TABLE 410 INDIA: SYNTHETIC BIOLOGY MARKET FOR MEDICAL APPLICATIONS, BY TYPE,  2020–2027 (USD MILLION)
                                TABLE 411 INDIA: SYNTHETIC BIOLOGY MARKET FOR DRUG DISCOVERY AND THERAPEUTICS,  BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 412 INDIA: SYNTHETIC BIOLOGY MARKET FOR ARTIFICIAL TISSUE AND TISSUE REGENERATION, BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 413 INDIA: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL APPLICATIONS, BY TYPE,  2020–2027 (USD MILLION)
                                TABLE 414 INDIA: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL ENZYMES, BY INDUSTRY,  2020–2027 (USD MILLION)
                                TABLE 415 INDIA: SYNTHETIC BIOLOGY MARKET FOR CONSUMER CARE INDUSTRY, BY TYPE,  2020–2027 (USD MILLION)
                                TABLE 416 INDIA: SYNTHETIC BIOLOGY MARKET FOR ENVIRONMENTAL APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 417 INDIA: SYNTHETIC BIOLOGY MARKET FOR FOOD AND AGRICULTURAL APPLICATIONS,  BY TYPE, 2020–2027 (USD MILLION)
           9.4.5 REST OF ASIA PACIFIC
                    TABLE 418 REST OF ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET, BY TOOL,  2020–2027 (USD MILLION)
                    TABLE 419 REST OF ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET, BY TECHNOLOGY,  2020–2027 (USD MILLION)
                    TABLE 420 REST OF ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET, BY APPLICATION,  2020–2027 (USD MILLION)
                    TABLE 421 REST OF ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR MEDICAL APPLICATIONS,  BY TYPE, 2020–2027 (USD MILLION)
                    TABLE 422 REST OF ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR DRUG DISCOVERY AND THERAPEUTICS, BY TYPE, 2020–2027 (USD MILLION)
                    TABLE 423 REST OF ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR ARTIFICIAL TISSUE AND TISSUE REGENERATION, BY TYPE, 2020–2027 (USD MILLION)
                    TABLE 424 REST OF ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL APPLICATIONS,  BY TYPE, 2020–2027 (USD MILLION)
                    TABLE 425 REST OF ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL ENZYMES,  BY INDUSTRY, 2020–2027 (USD MILLION)
                    TABLE 426 REST OF ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR CONSUMER CARE INDUSTRY, BY TYPE, 2020–2027 (USD MILLION)
                    TABLE 427 REST OF ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR ENVIRONMENTAL APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)
                    TABLE 428 REST OF ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR FOOD AND AGRICULTURAL APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)
           9.4.6 RECESSION IMPACT
    9.5 LATIN AMERICA 
          TABLE 429 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
          TABLE 430 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET, BY TOOL, 2020–2027 (USD MILLION)
          TABLE 431 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET, BY TECHNOLOGY,  2020–2027 (USD MILLION)
          TABLE 432 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET, BY APPLICATION,  2020–2027 (USD MILLION)
          TABLE 433 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)
          TABLE 434 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR DRUG DISCOVERY AND THERAPEUTICS, BY TYPE, 2020–2027 (USD MILLION)
          TABLE 435 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR ARTIFICIAL TISSUE AND TISSUE REGENERATION, BY TYPE, 2020–2027 (USD MILLION)
          TABLE 436 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)
          TABLE 437 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL ENZYMES, BY INDUSTRY, 2020–2027 (USD MILLION)
          TABLE 438 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR CONSUMER CARE INDUSTRY,  BY TYPE, 2020–2027 (USD MILLION)
          TABLE 439 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR ENVIRONMENTAL APPLICATIONS,  BY TYPE, 2020–2027 (USD MILLION)
          TABLE 440 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR FOOD AND AGRICULTURAL APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)
           9.5.1 BRAZIL
                    9.5.1.1 Growing pharmaceutical industry to drive market
                                TABLE 441 BRAZIL: SYNTHETIC BIOLOGY MARKET, BY TOOL, 2020–2027 (USD MILLION)
                                TABLE 442 BRAZIL: SYNTHETIC BIOLOGY MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)
                                TABLE 443 BRAZIL: SYNTHETIC BIOLOGY MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
                                TABLE 444 BRAZIL: SYNTHETIC BIOLOGY MARKET FOR MEDICAL APPLICATIONS, BY TYPE,  2020–2027 (USD MILLION)
                                TABLE 445 BRAZIL: SYNTHETIC BIOLOGY MARKET FOR DRUG DISCOVERY AND THERAPEUTICS,  BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 446 BRAZIL: SYNTHETIC BIOLOGY MARKET FOR ARTIFICIAL TISSUE AND TISSUE REGENERATION, BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 447 BRAZIL: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL APPLICATIONS, BY TYPE,  2020–2027 (USD MILLION)
                                TABLE 448 BRAZIL: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL ENZYMES, BY INDUSTRY,  2020–2027 (USD MILLION)
                                TABLE 449 BRAZIL: SYNTHETIC BIOLOGY MARKET FOR CONSUMER CARE INDUSTRY, BY TYPE,  2020–2027 (USD MILLION)
                                TABLE 450 BRAZIL: SYNTHETIC BIOLOGY MARKET FOR ENVIRONMENTAL APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 451 BRAZIL: SYNTHETIC BIOLOGY MARKET FOR FOOD AND AGRICULTURAL APPLICATIONS,  BY TYPE, 2020–2027 (USD MILLION)
           9.5.2 MEXICO
                    9.5.2.1 Increasing support for biotechnology infrastructure development to drive market
                                TABLE 452 MEXICO: SYNTHETIC BIOLOGY MARKET, BY TOOL, 2020–2027 (USD MILLION)
                                TABLE 453 MEXICO: SYNTHETIC BIOLOGY MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION)
                                TABLE 454 MEXICO: SYNTHETIC BIOLOGY MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
                                TABLE 455 MEXICO: SYNTHETIC BIOLOGY MARKET FOR MEDICAL APPLICATIONS, BY TYPE,  2020–2027 (USD MILLION)
                                TABLE 456 MEXICO: SYNTHETIC BIOLOGY MARKET FOR DRUG DISCOVERY AND THERAPEUTICS,  BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 457 MEXICO: SYNTHETIC BIOLOGY MARKET FOR ARTIFICIAL TISSUE AND TISSUE REGENERATION, BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 458 MEXICO: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL APPLICATIONS, BY TYPE,  2020–2027 (USD MILLION)
                                TABLE 459 MEXICO: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL ENZYMES, BY INDUSTRY,  2020–2027 (USD MILLION)
                                TABLE 460 MEXICO: SYNTHETIC BIOLOGY MARKET FOR CONSUMER CARE INDUSTRY, BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 461 MEXICO: SYNTHETIC BIOLOGY MARKET FOR ENVIRONMENTAL APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 462 MEXICO: SYNTHETIC BIOLOGY MARKET FOR FOOD AND AGRICULTURAL APPLICATIONS,  BY TYPE, 2020–2027 (USD MILLION)
           9.5.3 REST OF LATIN AMERICA
                    TABLE 463 REST OF LATIN AMERICA: SYNTHETIC BIOLOGY MARKET, BY TOOL,  2020–2027 (USD MILLION)
                    TABLE 464 REST OF LATIN AMERICA: SYNTHETIC BIOLOGY MARKET, BY TECHNO LOGY, 2020–2027 (USD MILLION)
                    TABLE 465 REST OF LATIN AMERICA: SYNTHETIC BIOLOGY MARKET, BY APPLICATION,  2020–2027 (USD MILLION)
                    TABLE 466 REST OF LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR MEDICAL APPLICATIONS,  BY TYPE, 2020–2027 (USD MILLION)
                    TABLE 467 REST OF LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR DRUG DISCOVERY AND THERAPEUTICS, BY TYPE, 2020–2027 (USD MILLION)
                    TABLE 468 REST OF LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR ARTIFICIAL TISSUE  AND TISSUE REGENERATION, BY TYPE, 2020–2027 (USD MILLION)
                    TABLE 469 REST OF LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)
                    TABLE 470 REST OF LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL ENZYMES,  BY INDUSTRY, 2020–2027 (USD MILLION)
                    TABLE 471 REST OF LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR CONSUMER CARE INDUSTRY, BY TYPE, 2020–2027 (USD MILLION)
                    TABLE 472 REST OF LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR ENVIRONMENTAL APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)
                    TABLE 473 REST OF LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR FOOD AND AGRICULTURAL APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)
           9.5.4 RECESSION IMPACT
    9.6 MIDDLE EAST AND AFRICA 
          TABLE 474 MIDDLE EAST & AFRICA: SYNTHETIC BIOLOGY MARKET, BY TOOL,  2020–2027 (USD MILLION)
          TABLE 475 MIDDLE EAST & AFRICA: SYNTHETIC BIOLOGY MARKET, BY TECHNOLOGY,  2020–2027 (USD MILLION)
          TABLE 476 MIDDLE EAST & AFRICA: SYNTHETIC BIOLOGY MARKET, BY APPLICATION,  2020–2027 (USD MILLION)
          TABLE 477 MIDDLE EAST & AFRICA: SYNTHETIC BIOLOGY MARKET FOR MEDICAL APPLICATIONS,  BY TYPE, 2020–2027 (USD MILLION)
          TABLE 478 MIDDLE EAST & AFRICA: SYNTHETIC BIOLOGY MARKET FOR DRUG DISCOVERY AND THERAPEUTICS, BY TYPE, 2020–2027 (USD MILLION)
          TABLE 479 MIDDLE EAST & AFRICA: SYNTHETIC BIOLOGY MARKET FOR ARTIFICIAL TISSUE AND TISSUE REGENERATION, BY TYPE, 2020–2027 (USD MILLION)
          TABLE 480 MIDDLE EAST & AFRICA: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)
          TABLE 481 MIDDLE EAST & AFRICA: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL ENZYMES,  BY INDUSTRY, 2020–2027 (USD MILLION)
          TABLE 482 MIDDLE EAST & AFRICA: SYNTHETIC BIOLOGY MARKET FOR CONSUMER CARE INDUSTRY, BY TYPE, 2020–2027 (USD MILLION)
          TABLE 483 MIDDLE EAST & AFRICA: SYNTHETIC BIOLOGY MARKET FOR ENVIRONMENTAL APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)
          TABLE 484 MIDDLE EAST & AFRICA: SYNTHETIC BIOLOGY MARKET FOR FOOD AND AGRICULTURAL APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)
           9.6.1 RECESSION IMPACT
 
10 COMPETITIVE LANDSCAPE (Page No. - 375)
     10.1 OVERVIEW 
     10.2 STRATEGIES ADOPTED BY KEY PLAYERS 
              FIGURE 22 STRATEGIES ADOPTED BY KEY PLAYERS IN SYNTHETIC BIOLOGY MARKET,  2019–2022
     10.3 REVENUE SHARE ANALYSIS 
     10.4 MARKET SHARE ANALYSIS 
              FIGURE 24 SYNTHETIC BIOLOGY MARKET SHARE ANALYSIS, BY KEY PLAYER, 2021
              TABLE 485 SYNTHETIC BIOLOGY MARKET: DEGREE OF COMPETITION
     10.5 COMPANY EVALUATION QUADRANT 
             10.5.1 STARS
             10.5.2 EMERGING LEADERS
             10.5.3 PERVASIVE PLAYERS
             10.5.4 PARTICIPANTS
                        FIGURE 25 SYNTHETIC BIOLOGY MARKET: COMPANY EVALUATION QUADRANT, 2021
     10.6 COMPANY EVALUATION QUADRANT: STARTUPS/SMES 
             10.6.1 PROGRESSIVE COMPANIES
             10.6.2 STARTING BLOCKS
             10.6.3 RESPONSIVE COMPANIES
             10.6.4 DYNAMIC COMPANIES
                        FIGURE 26 SYNTHETIC BIOLOGY MARKET: COMPANY EVALUATION QUADRANT FOR STARTUPS/SMES, 2021
     10.7 COMPANY FOOTPRINT ANALYSIS 
     10.8 PRODUCT FOOTPRINT ANALYSIS 
              TABLE 486 PRODUCT FOOTPRINT ANALYSIS OF COMPANIES IN SYNTHETIC BIOLOGY MARKET (2022)
     10.9 REGIONAL FOOTPRINT ANALYSIS 
              TABLE 487 REGIONAL FOOTPRINT ANALYSIS OF COMPANIES IN SYNTHETIC BIOLOGY MARKET (2022)
     10.10 COMPETITIVE SCENARIO 
              TABLE 488 SYNTHETIC BIOLOGY MARKET: PRODUCT/SERVICE LAUNCHES, JANUARY 2019–DECEMBER 2022
              TABLE 489 SYNTHETIC BIOLOGY MARKET: DEALS, JANUARY 2019–DECEMBER 2022
              TABLE 490 SYNTHETIC BIOLOGY MARKET: OTHER DEVELOPMENTS, JANUARY 2019–DECEMBER 2022
 
11 COMPANY PROFILES (Page No. - 390)
     11.1 KEY MARKET PLAYERS 
                        Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
             11.1.1 THERMO FISHER SCIENTIFIC INC.
                        TABLE 491 THERMO FISHER SCIENTIFIC INC.: BUSINESS OVERVIEW
                        FIGURE 27 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2021)
             11.1.2 MERCK KGAA
                        TABLE 492 MERCK KGAA: BUSINESS OVERVIEW
                        FIGURE 28 MERCK KGAA: COMPANY SNAPSHOT (2021)
             11.1.3 NOVOZYMES (A NOVO HOLDINGS A/S COMPANY)
                        TABLE 493 NOVOZYMES: BUSINESS OVERVIEW
                        FIGURE 29 NOVOZYMES: COMPANY SNAPSHOT (2021)
             11.1.4 EUROFINS SCIENTIFIC
                        TABLE 494 EUROFINS SCIENTIFIC: BUSINESS OVERVIEW
                        FIGURE 30 EUROFINS SCIENTIFIC: COMPANY SNAPSHOT (2021)
             11.1.5 AGILENT TECHNOLOGIES
                        TABLE 495 AGILENT TECHNOLOGIES: BUSINESS OVERVIEW
                        FIGURE 31 AGILENT TECHNOLOGIES: COMPANY SNAPSHOT (2021)
             11.1.6 AMYRIS
                        TABLE 496 AMYRIS: BUSINESS OVERVIEW
                        FIGURE 32 AMYRIS: COMPANY SNAPSHOT (2021)
             11.1.7 CODEXIS, INC.
                        TABLE 497 CODEXIS, INC.: BUSINESS OVERVIEW
                        FIGURE 33 CODEXIS, INC.: COMPANY SNAPSHOT (2021)
             11.1.8 TWIST BIOSCIENCE
                        TABLE 498 TWIST BIOSCIENCE: BUSINESS OVERVIEW
                        FIGURE 34 TWIST BIOSCIENCE: COMPANY SNAPSHOT (2021)
             11.1.9 GENSCRIPT
                        TABLE 499 GENSCRIPT: BUSINESS OVERVIEW
                        FIGURE 35 GENSCRIPT: COMPANY SNAPSHOT (2021)
             11.1.10 PRECIGEN
                        TABLE 500 PRECIGEN: BUSINESS OVERVIEW
                        FIGURE 36 PRECIGEN: COMPANY SNAPSHOT (2021)
             11.1.11 GINKGO BIOWORKS
                        TABLE 501 GINKGO BIOWORKS: BUSINESS OVERVIEW
                        FIGURE 37 GINKGO BIOWORKS: COMPANY SNAPSHOT (2021)
             11.1.12 VIRIDOS (FORMERLY KNOWN AS SYNTHETIC GENOMICS)
                        TABLE 502 VIRIDOS (SYNTHETIC GENOMICS): BUSINESS OVERVIEW
             11.1.13 SYNTHEGO
                        TABLE 503 SYNTHEGO: BUSINESS OVERVIEW
             11.1.14 CREATIVE ENZYMES
                        TABLE 504 CREATIVE ENZYMES: BUSINESS OVERVIEW
             11.1.15 CYRUS BIOTECHNOLOGY
                        TABLE 505 CYRUS BIOTECHNOLOGY: BUSINESS OVERVIEW
     11.2 OTHER PLAYERS 
             11.2.1 ATUM
             11.2.2 TESELAGEN
             11.2.3 ARZEDA
             11.2.4 INTEGRATED DNA TECHNOLOGIES
             11.2.5 NEW ENGLAND BIOLABS
             11.2.6 ELEVATEBIO
             11.2.7 ZENFOLD (IOSYNTH)
             11.2.8 SYNBIO TECHNOLOGIES
             11.2.9 INSCRIPTA, INC.
             11.2.10 CRISPR THERAPEUTICS
 
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
 
12 APPENDIX (Page No. - 450)
     12.1 DISCUSSION GUIDE 
     12.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 
     12.3 CUSTOMIZATION OPTIONS 
     12.4 RELATED REPORTS 
     12.5 AUTHOR DETAILS 

This study involved four major activities in estimating the current size of the synthetic biology market. Exhaustive secondary research was carried out to collect information on the market, its peer markets, and its parent market. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. After that, market breakdown and data triangulation procedures were used to estimate the market size of segments and subsegments.

Secondary Research

Secondary research was used mainly to identify and collect information for the extensive, technical, market-oriented, and commercial study of the synthetic biology market. The secondary sources referred to for this research study include publications from government and private sources such as the World Health Organization (WHO), Organisation for Economic Co-operation and Development (OECD), Lens.org, National Center for Biotechnology Information (NCBI), Imperial College Centre for Synthetic Biology, Institute of Systems & Synthetic Biology (iSSB), University of California San Francisco (UCSF), Center for Systems and Synthetic Biology, Synthetic Biology Leadership Council (SBLC), Engineering Biology Advisory Committee, Synthetic Biology Engineering Research Center (SynBERC), Biotechnology and Biological Sciences Research Council (BBSRC), Helmholtz Association of German Research Centres, Asian Synthetic Biology Association, World Bank, Academic Journals, Company Websites, Expert Interviews, Annual Reports, SEC Filings, Investor Presentations, and MarketsandMarkets Analysis. Secondary data was collected and analyzed to arrive at the overall size of the global synthetic biology market, which was then validated by primary research.

Primary Research

In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, among other experts, to obtain and verify the critical qualitative and quantitative information as well as assess future prospects of the market. Various primary sources from both the supply and demand sides of the market were interviewed to obtain qualitative and quantitative information. The following is a breakdown of the primary respondents:

Synthetic Biology Market Size

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

Both top-down and bottom-up approaches were used to estimate and validate the total size of the synthetic biology market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

  • The key players in the industry and market have been identified through extensive secondary research
  • The revenues generated from the synthetic biology business of leading players have been determined through primary and secondary research
  • All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources

Data Triangulation

After arriving at the overall market size from the market size estimation process, the total market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides.

Report Objectives

  • To define, describe, and forecast the global synthetic biology market based on the tool, technology, application, and region
  • To provide detailed information regarding the major factors influencing the growth of the market (such as drivers, restraints, challenges, opportunities, and trends)
  • To strategically analyze micromarkets with respect to individual growth trends, future prospects, and contributions to the overall synthetic biology market
  • To analyze opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
  • To forecast the size of the market segments with respect to five main regions, namely, North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
  • To strategically profile the key players and comprehensively analyze their product portfolios, market positions, and core competencies
  • To track and analyze competitive developments such as acquisitions, product launches, expansions, agreements, partnerships, and R&D activities in the synthetic biology market.

Available Customizations

With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for this report:

Geographic Analysis

  • Further breakdown of the Rest of Europe synthetic biology market into respective countries
  • Further breakdown of the Rest of Asia Pacific synthetic biology market into respective countries
  • Further breakdown of the Rest of Latin America synthetic biology market into respective countries

Company Information

  • Detailed analysis and profiling of additional market players (Up to 5)
Report Code
BT 2910
Published ON
Feb, 2023
Choose License Type
BUY NOW
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the Synthetic Biology Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
CUSTOMIZED WORKSHOP REQUEST
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
©2023 MarketsandMarkets Research Private Ltd. All rights reserved
DMCA.com Protection Status Website Feedback